Early Access — free while we kick the tires
EdgarHawk

5AM Partners VI, LLC

10% Owner

10% Owner
3 filings analyzed · 2 companies · Latest 2025-09-15

Companies

Company Buys Sells Direction
Camp4 Therapeutics Corp CAMP 4 0 Net buying
Artiva Biotherapeutics, Inc. ARTV 4 0 Net buying

Activity

September 2025
high
Buy
2,941,176 shares
$4,499,999
Significance 6/10

10% Owner 5AM Partners VI buys 2.94M shares of CAMP at $1.53; stock now -77.4% from 52-week high amid unprofitable operations and cluster buy pattern.

5AM Partners VI purchased 2,941,176 shares at $1.53 on 2025-09-11, representing a new 2.94M share position in Camp4 Therapeutics. The current price of $2.65 reflects a -77.4% decline from the 52-week high of $11.74, though the stock has recovered +58.7% over the past 30 days and +90.6% over 90 days. Historically, this insider's prior buy at CAMP on 2024-10-15 posted a 90-day return of -64.1%, and across all tickers, the insider's 2 prior buys averaged a 90-day return of -31.3%. The transaction occurs alongside a cluster of 6 other insiders who bought within the past 14 days. Camp4 remains unprofitable with a net income of $-12,587,000.00 over its most recent full fiscal year, though the company posted +86.3% annual revenue growth. The $53.4M market cap and severe valuation compression create a high-risk recovery narrative that the cluster activity does not validate based on the insider's prior track record at this same ticker.

October 2024
high
Buy
909,090 shares
$9,999,990
Significance 7/10

10% owner 5AM Partners VI buys 909,090 shares ($10.0M) at $11.00 as stock hits 52-week high; 6 other insiders bought in past 14 days

5AM Partners VI, a 10% shareholder in Camp4 Therapeutics, deployed $9,999,990.00 to purchase 909,090 shares at $11.00 on 2024-10-15, increasing its position from 1,716,055 shares to 2,625,145 shares (+53.0%). This transaction occurred at the stock's 52-week high of $10.75 (transaction at $11.00 slightly above current), representing a significant capital commitment. The CLUSTER pattern—6 other insiders also buying within the past 14 days—indicates coordinated conviction among multiple directors and executives. Across 5AM Partners VI's cross-ticker track record, prior buys averaged -1.7% 30-day returns, but this particular filing's timing at the 52-week high and the breadth of concurrent insider accumulation merit close monitoring for potential underwriting or financing context.

July 2024
high
Buy
833,333 shares
$9,999,996
Significance 7/10

5AM Partners VI acquired 833,333 shares of ARTV at $12.00 (7/22) in $10.0M purchase amid cluster buy pattern

5AM Partners VI, a 10% owner, purchased 833,333 shares at $12.00 on 2024-07-22 for $9,999,996.00, expanding its holdings from 348,721 shares to 1,182,054 shares—a 239.0% increase. This transaction coincides with a cluster pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated conviction during the company's early post-IPO phase (4 trading days into listing). The current price of $11.80 as of 2024-07-24 reflects slight softening from the transaction price, though 52-week metrics remain uninformative. Note: This filing involves derivative-conversion activity; the insider's full position includes Table II derivative securities not yet populated in this database, so the reported common shares should not be interpreted as the complete post-transaction holdings.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access